Details for New Drug Application (NDA): 074821
✉ Email this page to a colleague
The generic ingredient in TRIAMTERENE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 074821
Tradename: | TRIAMTERENE AND HYDROCHLOROTHIAZIDE |
Applicant: | Sandoz |
Ingredient: | hydrochlorothiazide; triamterene |
Patents: | 0 |
Pharmacology for NDA: 074821
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Suppliers and Packaging for NDA: 074821
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | CAPSULE;ORAL | 074821 | ANDA | Sandoz Inc | 0781-2074 | 0781-2074-01 | 100 CAPSULE in 1 BOTTLE (0781-2074-01) |
TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | CAPSULE;ORAL | 074821 | ANDA | Sandoz Inc | 0781-2074 | 0781-2074-10 | 1000 CAPSULE in 1 BOTTLE (0781-2074-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG;37.5MG | ||||
Approval Date: | Jun 5, 1997 | TE: | AB | RLD: | No |
Complete Access Available with Subscription